Virus Outbreak Novavax Vaccine
Maryland (77WABC)-Maryland-based vaccine maker Novavax says it’s Covid 19 vaccine is highly effective against the Covid 19 vaccine and variants. The potential Covid 19 vaccine is now in its third phase of clinical trials.
The Maryland-based company on Monday announced results from a large, late-stage study in the U.S. and Mexico that found its vaccine was about 90% effective. Preliminary data also showed it was safe.
Learn about our investigational vaccine candidate, Novavax #vaccine technology, our #COVID19 #clinicaltrial results and more at: https://t.co/GOBsIgkYCv
— Novavax (@Novavax) June 14, 2021
Novavax previously released results from smaller studies in Britain and South Africa. By the end of September, Novavax plans to file for emergency use authorization in the U.S., Europe, and elsewhere.
Novavax’s vaccine is made by growing harmless copies of the coronavirus spike protein in the laboratory.
